The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population
Open accessAbstract
We have performed a detailed population study of patients with genetic muscle disease in the northern region of England. Our current clinic population comprises over 1100 patients in whom we have molecularly characterized 31 separate muscle disease entities. Diagnostic clarity achieved through careful delineation of clinical features supported by histological, immunological and genetic analysis has allowed us to reach a definitive diagnosis in 75.7% of our patients. We have compared our case profile with that from Walton and Nattrass' seminal study from 1954, also of the northern region, together with data from other more recent studies from around the world. Point prevalence figures for each of the five major disease categories are comparable with those from other recent studies. Myotonic dystrophies are the most common, comprising 28.6% of our clinic population with a point prevalence of 10.6/100,000. Next most frequent are the dystrophinopathies and facioscapulohumeral muscular dystrophy making up 22.9% (8.46/100,000) and 10.7% (3.95/100,000) of the clinic population, respectively. Spinal muscular atrophy patients account for 5.1% or 1.87/100,000 patients. Limb girdle muscular dystrophy, which was described for the first time in the paper by Walton and Nattrass (1954) and comprised 17% of their clinic population, comprises 6.2% of our clinic population at a combined prevalence of 2.27/100,000. The clinic population included patients with 12 other muscle disorders. These disorders ranged from a point prevalence of 0.89/100 000 for the group of congenital muscular dystrophies to conditions with only two affected individuals in a population of three million. For the first time our study provides epidemiological information for X-linked Emery-Dreifuss muscular dystrophy and the collagen VI disorders. Each of the X-linked form of Emery-Dreifuss muscular dystrophy and Ullrich muscular dystrophy has a prevalence of 0.13/100,000, making both very rare. Bethlem myopathy was relatively more common with a prevalence of 0.77/100,000. Overall our study provides comprehensive epidemiological information on individually rare inherited neuromuscular conditions in Northern England. Despite the deliberate exclusion of relatively common groups such as hereditary motor and sensory neuropathy (40/100,000) and mitochondrial disorders (9.2/100,000), the combined prevalence is 37.0/100,000, demonstrating that these disorders, taken as a group, encompass a significant proportion of patients with chronic disease. The study also illustrates the immense diagnostic progress since the first regional survey over 50 years ago by Walton and Nattrass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,448
Eagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00140-2 · Cited by 1,009
Self-citationHarper, P. S. (2001) · Cited by 908
Wirth, B. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3<228::aid-humu3>3.0.co;2-9 · Cited by 667
ON THE CLASSIFICATION, NATURAL HISTORY AND TREATMENT OF THE MYOPATHIES
WALTON, J. N., & NATTRASS, F. J. (1954) · Brain · doi:10.1093/brain/77.2.169 · Cited by 541
Prevalence of mitochondrial DNA disease in adults
Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R. W., Chinnery, P. F., & Turnbull, D. M. (2008) · Annals of Neurology · doi:10.1002/ana.21217 · Cited by 494
Self-citationAusems, M., Verbiest, J., Hermans, M., Kroos, M., Beemer, F., Wokke, J., Sandkuijl, L., Reuser, A., & van der Ploeg, A. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200367 · Cited by 307
Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden
Darin, N., & Tulinius, M. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00055-3 · Cited by 205
Guglieri, M., Magri, F., D’Angelo, M. G., Prelle, A. C., Morandi, L. O., Rodolico, C., Cagliani, R., Mora, M., Fortunato, F., Bordoni, A., et al. (2007) · Human Mutation · doi:10.1002/humu.20642 · Cited by 202
Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England
Robertson, N. P., Deans, J., & Compston, D. A. S. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.4.492 · Cited by 187
Limb-Girdle Muscular Dystrophy in the United States
Moore, S. A., Shilling, C. J., Westra, S., Wall, C., Wicklund, M. P., Stolle, C., Brown, C. A., Michele, D. E., Piccolo, F., Winder, T. L., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235854.77716.6c · Cited by 181
LGMD2A: genotype–phenotype correlations based on a large mutational survey on the calpain 3 gene
Sáenz, A., Leturcq, F., Cobo, A. M., Poza, J. J., Ferrer, X., Otaegui, D., Camaño, P., Urtasun, M., Vílchez, J., Gutiérrez-Rivas, E., et al. (2005) · Brain · doi:10.1093/brain/awh408 · Cited by 175
Multiplex Western Blotting System for the Analysis of Muscular Dystrophy Proteins
Anderson, L. V. B., & Davison, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65354-0 · Cited by 172
Mostacciuolo, M., Pastorello, E., Vazza, G., Miorin, M., Angelini, C., Tomelleri, G., Galluzzi, G., & Trevisan, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01158.x · Cited by 170
Sveen, M., Schwartz, M., & Vissing, J. (2006) · Annals of Neurology · doi:10.1002/ana.20824 · Cited by 170
Bachinski, L. L., Udd, B., Meola, G., Sansone, V., Bassez, G., Eymard, B., Thornton, C. A., Moxley, R. T., Harper, P. S., Rogers, M. T., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378566 · Cited by 142
Bernatsky, S., Joseph, L., Pineau, C. A., Bélisle, P., Boivin, J.-F., Banerjee, D. K., & Clarke, A. E. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093161 · Cited by 141
Muscular Dystrophies Due to Glycosylation Defects
Muntoni, F., Torelli, S., & Brockington, M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.005 · Cited by 126
EFNS guideline on diagnosis and management of limb girdle muscular dystrophies
Norwood, F., Visser, M., Eymard, B., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01979.x · Cited by 126
Self-citationFacioscapulohumeral muscular dystrophy in the dutch population
Padberg, G. W. A. M., Frants, R. R., Brouwer, O. F., Wijmenga, C., Bakker, E., & Sandkuijl, L. A. (1995) · Muscle & Nerve · doi:10.1002/mus.880181315 · Cited by 124
Prevalence of sporadic inclusion body myositis in Western Australia
Phillips, B. A., Zilko, P. J., & Mastaglia, F. L. (2000) · Muscle & Nerve · Cited by 114
Diagnosis and etiology of congenital muscular dystrophy
Peat, R. A., Smith, J. M., Compton, A. G., Baker, N. L., Pace, R. A., Burkin, D. J., Kaufman, S. J., Lamandé, S. R., & North, K. N. (2007) · Neurology · doi:10.1212/01.wnl.0000284605.27654.5a · Cited by 104
The prevalence of inherited neuromuscular disease in Northern Ireland
Hughes, M. I., Hicks, E. M., Nevin, N. C., & Patterson, V. (1996) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)00017-4 · Cited by 95
Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations.
Davies, J. L., Yamagata, H. D., Shelbourne, P., Buxton, J. L., Ogihara, T., Nokelainen, P. T., Nakagawa, M., Williamson, R., Johnson, K. J., & Miki, T. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.11.766 · Cited by 89
Haller, R. G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.923 · Cited by 84
Congenital muscular dystrophies: New aspects of an expanding group of disorders
Lisi, M. T., & Cohn, R. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.006 · Cited by 74
Neurology and Clinical Neuroscience
(2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03354-1.x5001-9 · Cited by 73
Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec
Yotova, V., Labuda, D., Ziętkiewicz, E., Gehl, D., Lovell, A. D., Lefebvre, J.-F., Bourgeois, S., Lemieux‐Blanchard, É., Labuda, M., Vézina, H., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1298-8 · Cited by 69
Selcen, D. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830a752b · Cited by 61
THE EPIDEMIOLOGY AND GENETICS OF MULTIPLE SCLEROSIS
Compston, A., & Sadovnick, A. D. (1999) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/00132979-199905050-00004 · Cited by 59
The limb-girdle muscular dystrophies—Diagnostic strategies
Bushby, K., Norwood, F., & Straub, V. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.009 · Cited by 42
Self-citationMolecular biology of distal muscular dystrophies—Sarcomeric proteins on top
Udd, B. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.08.005 · Cited by 42
Balcı, B., Aurino, S., Haliloğlu, G., et al. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-005-0046-3 · Cited by 39
Dysferlinopathy in the Jews of the Caucasus: A frequent mutation in the dysferlin gene
Leshinsky‐Silver, E., Argov, Z., Rozenboim, L., Cohen, S., Tzofi, Z., Cohen, Y., Wirguin, Y., Dabby, R., Lev, D., & Sadeh, M. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.07.010 · Cited by 39
Limb-girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms.
Angelini, C. I. (2004) · PubMed · Cited by 29
Dunø, M., Sveen, M., Schwartz, M., & Vissing, J. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.47 · Cited by 29
Goebel, H., & Fardeau, M. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.08.003 · Cited by 23
Goebel, H. H., Fardeau, M., Olivé, M., & Schröder, R. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.04.008 · Cited by 16
Jungbluth, H., Sewry, C. A., & Muntoni, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00093-0 · Cited by 3
Cited by
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
Self-citationPrevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24362 · Cited by 936
Self-citationVerhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmüller, H. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0671-8 · Cited by 739
Mercuri, E., Bönnemann, C. G., & Muntoni, F. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32910-1 · Cited by 551
Metadata
- Authors
- Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-18
- Volume
- 132
- Issue
- 11
- Pages
- 3175-3186
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2084703547
- Cited by
- 541
- References
- 39
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.